A focus on the nowadays potential antiviral strategies in early phase of coronavirus disease 2019 (Covid-19): A narrative review
C Monari, V Gentile, C Camaioni, G Marino, N Coppola… - Life, 2020 - mdpi.com
Background: The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection and the related disease (COVID-19) has rapidly spread to a pandemic …
CoV-2) infection and the related disease (COVID-19) has rapidly spread to a pandemic …
Anti COVID-19 drugs: need for more clinical evidence and global action
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
Updated approaches against SARS-CoV-2
H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
[HTML][HTML] Natural history of COVID-19 and current knowledge on treatment therapeutic options
WG Dos Santos - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Despite intense research there is currently no effective vaccine available against the new
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients
S Bellino - Annals of medicine, 2022 - Taylor & Francis
Background The COVID-19 pandemic caused by SARS-CoV-2 continues to have a serious
impact on public health worldwide. Most patients develop mild to moderate symptoms and …
impact on public health worldwide. Most patients develop mild to moderate symptoms and …
A comprehensive review on the efficacy of several pharmacologic agents for the treatment of COVID-19
Simple Summary Treatments for coronavirus disease-2019 (COVID-19) have utilized a
variety of medications, including antivirals, immunomodulators, and other therapeutics such …
variety of medications, including antivirals, immunomodulators, and other therapeutics such …
[HTML][HTML] Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo …
Q Cheng, J Chen, Q Jia, Z Fang, G Zhao - Aging (albany NY), 2021 - ncbi.nlm.nih.gov
Background: Many recent studies have investigated the role of drug interventions for
coronavirus disease 2019 (COVID-19) infection. However, an important question has been …
coronavirus disease 2019 (COVID-19) infection. However, an important question has been …
Treatments administered to the first 9152 reported cases of COVID-19: a systematic review
DC Fajgenbaum, JS Khor, A Gorzewski… - Infectious diseases and …, 2020 - Springer
The emergence of SARS-CoV-2/2019 novel coronavirus (COVID-19) has created a global
pandemic with no approved treatments or vaccines. Many treatments have already been …
pandemic with no approved treatments or vaccines. Many treatments have already been …
Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges
X Yang, Y Liu, Y Liu, Q Yang, X Wu… - Expert Review of …, 2020 - Taylor & Francis
Introduction The coronavirus disease 2019 (COVID-19) pandemic has spread globally since
it outbroke in December 2019. The urgent pandemic presents an unprecedented challenge …
it outbroke in December 2019. The urgent pandemic presents an unprecedented challenge …
An update on emerging therapeutics to combat COVID‐19
Background The COVID‐19 pandemic has demanded effective therapeutic protocol from
researchers and clinicians across the world. Currently, a large amount of primary data have …
researchers and clinicians across the world. Currently, a large amount of primary data have …